Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for RLN Identification in Thyroidectomy
NCT07067814Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in nodular goiter, thyroid nodule, Hyperfunctioning Multinodular Goiter (MNG), sponsored by Ain Shams University. Started Jun 2023; status: completed.
02
Drugs
methylene blue
03
Conditions
nodular goiterthyroid noduleHyperfunctioning Multinodular Goiter (MNG)
Beyond the preview
Go deeper on NCT07067814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07067814.